Key takeaways
Without insurance, Wegovy injection costs $199–$399 per month, and the Wegovy pill costs $149–$299 per month, depending on the dose, on Ro.
Both the Wegovy pen and pill have a list price of $1,349.02 per month.
With insurance, Wegovy can cost as little as $0–$25, but the exact price depends on your plan details.
With the cash price of $149–$299 on Ro, the Wegovy pill is one of the cheapest FDA-approved GLP-1s on the market.
Here's what we'll cover
Key takeaways
Without insurance, Wegovy injection costs $199–$399 per month, and the Wegovy pill costs $149–$299 per month, depending on the dose, on Ro.
Both the Wegovy pen and pill have a list price of $1,349.02 per month.
With insurance, Wegovy can cost as little as $0–$25, but the exact price depends on your plan details.
With the cash price of $149–$299 on Ro, the Wegovy pill is one of the cheapest FDA-approved GLP-1s on the market.
The cost of Wegovy (semaglutide) can be prohibitive for some potential patients. But there are ways to get the weight loss medication for far less than its list price of $1,349.02 per month.
Read on to learn more about Wegovy cost with and without insurance — plus ways to save on your prescription and potentially cheaper Wegovy alternatives.
How much does Wegovy cost without insurance?
Without insurance, Wegovy’s list price is $1,349.02. But you can get Wegovy for as little as $149 per month, depending on the form (pill vs. injection) and dose, on Ro.
Here’s how much Wegovy costs without insurance — i.e. the cash-pay prices — on Ro:
Wegovy pill | Wegovy pen |
1.5 mg: $149 per month 4 mg: $149 per month* 9 mg: $299 per month 25 mg: $299 per month | 0.25 mg: $199 per month* 0.5 mg: $199 per month* 1 mg: $349 per month 1.7 mg: $349 per month 2.4 mg: $349 per month 7.2 mg: $399 per month |
*These prices are available as part of a limited-time offer. See here for more details.
There isn’t currently a generic version of Wegovy, and it will likely be some time before one becomes available. Until then, these cash-pay prices are the cheapest way to get Wegovy without insurance.
How much does Wegovy cost with insurance?
Depending on your insurance plan, you might be able to get Wegovy for free. If it’s not completely covered, you may be able to get Wegovy for as low as $25 per month with the manufacturer’s Wegovy savings offer.
To get the official $25 Wegovy savings offer, you’ll need to apply on the drug manufacturer’s website. You’ll also need to meet certain eligibility requirements, including having a commercial insurance plan that covers Wegovy. Those with insurance through Medicare, Medicaid, and other government-funded programs are not eligible.
If you’re a veteran receiving care through the US Department of Veteran Affairs (VA), you may be able to get Wegovy covered as part of your treatment plan under the MOVE! Weight Management Program.
Not sure if Wegovy is covered by your insurance plan? There are a few ways to find out:
1. Review your plan’s drug formulary. This lists all the medications covered in your plan, and can typically be found online. If Wegovy is not listed, your healthcare provider can write an appeal letter on your behalf to your insurance company requesting an exception.
2. Contact your plan directly. Once you reach a representative, ask if your plan covers Wegovy. If they say “yes,” then consider asking for the expected copay or coinsurance and the specific steps required for you to receive coverage (e.g. submitting prior authorization).
3. Use Ro’s GLP-1 Insurance Coverage Checker. This is a free tool available to everyone (meaning, not just Ro Body members). Simply fill out the online form with the details on your insurance card, and Ro will reach out to your plan directly and then send you a free, personalized coverage report.
Is Wegovy covered by Medicaid?
Medicaid coverage for Wegovy varies by state. As of January 2026, 13 states offer GLP-1 coverage for obesity.
Check your plan’s formulary or contact your state Medicaid agency to see if Wegovy is covered. If Wegovy is covered, your Medicaid plan may require prior authorization.
Is Wegovy covered by Medicare?
Medicare may cover Wegovy if prescribed for cardiovascular disease. But Wegovy is not covered if it is prescribed for the treatment of obesity without pre-existing cardiovascular disease.
Recent federal programs may expand access and lower GLP-1 costs in the near future. A Medicaid rollout is expected in May 2026, and Medicare Part D coverage may begin in July 2026.
How to get Wegovy
Since Wegovy is a prescription drug, you will need an Rx from a licensed healthcare provider to get Wegovy. You can schedule an appointment with your provider to see about getting a prescription for Wegovy.
Another option to get Wegovy is on Ro. The Ro Body membership helps people lose an average of 15% of their body weight by pairing a GLP-1 medication (e.g. Wegovy) with personal coaching, support, and guidance, as well as Ro’s evidence-backed weight loss curriculum.
You’ll also get access to a concierge team that will work with your insurance provider to find coverage for GLP-1 medication if prescribed. If you’re denied for one medication (or insurance stops covering it in the future), a customer service partner will work to help you find alternatives if appropriate. (FYI, you can get started on Ro here.)
How to get a Wegovy coupon
Wegovy coupons are another way to save on Wegovy. You can use the official manufacturer savings offer or download pharmacy discount cards from sites such as SingleCare or GoodRx.
Here’s how to get (and use!) these Wegovy coupons:
Pharmacy discount cards. Visit a site that offers these coupons, such as SingleCare, GoodRx, WellRx, Optum Perks, or BuzzRx. Enter your location, and the site will show you a list of discounted prices for pharmacies in your area. Look up your prescription for Wegovy, and save or print the discount card to show to your pharmacist.
Manufacturer’s savings offer. Offered by the drug’s manufacturer, Novo Nordisk, the Wegovy Savings Card is meant for people with commercial health insurance. If your insurance covers Wegovy (and you meet the other eligibility requirements), you can pay as little as $25 for a one-month supply of Wegovy. Those with insurance that does not cover Wegovy or government-funded insurance aren’t eligible for the offer.
Are there cheaper alternatives to Wegovy?
The cash-pay prices for Wegovy available on Ro make it one of the more affordable GLP-1s out there. But the drug, like so many Rx treatments, can still be expensive.
Below we’ve listed some common alternatives to Wegovy and their average monthly cost, without insurance. Some of these may be cheaper out-of-pocket, while others may be more expensive (but cheaper if they’re covered by your insurance).
Wegovy alternative | Monthly cost without insurance | Cheaper than Wegovy? |
Foundayo (orforglipron) | $149–$299* | Depends on the dose |
Ozempic (semaglutide) | $199–$1,027.51 | No, unless covered by insurance |
Mounjaro (tirzepatide) | $1,112.16 | No, unless covered by insurance |
Zepbound (tirzepatide) | $299–$1,086.37 | No, unless covered by insurance |
Saxenda (liraglutide) | $1,349.02 | No, unless covered by insurance |
Qsymia (phentermine/topiramate) | $70–$98 | Yes |
Contrave (naltrexone/bupropion) | $199–$210 | Sometimes, depending on the dosage |
Xenical (orlistat) | $430–$725 | No, unless covered by insurance |
Alli (orlistat) | $55–$90 | Yes |
*With manufacturer offer
Foundayo (orforglipron)
Foundayo is an oral GLP-1 that’s FDA-approved for weight loss and management in adults with obesity or with overweight and at least one weight-related health condition. It should be used in combination with a reduced-calorie diet and increased physical activity.
Unlike the Wegovy pill, Foundayo can be taken any time of day, with or without food. This is thanks to its active ingredient, orforglipron, which is a non-peptide. Meaning, it has a more stable molecular structure that allows it to be better absorbed in the gut.
Like the Wegovy pill, however, Foundayo starts at $149 per month when paying cash on Ro, and lower doses of the drug cost less than higher ones. Here’s a breakdown of the cash-pay cost of Foundayo:
$149 per month: 0.8 mg dose
$199 per month: 2.5 mg dose
$299 per month: 5.5 mg and 9 mg doses
$299 per month: 14.5 mg and 17.2 mg doses (with manufacturer offer)
Foundayo can also cost as little as $25 per month if you have commercial insurance that covers the drug and are eligible for the official Foundayo Savings Card. (Yup, also similar to the Wegovy pill.) If your plan doesn’t include coverage for Foundayo, the card caps your monthly cost at $149 for the starting dose, $199 for 2.5 mg, and $299–$349 for the higher doses.
Ozempic (semaglutide)
Ozempic and Wegovy are made by the same manufacturer, Novo Nordisk, and contain the same active ingredient, semaglutide.
Both are meant to be used alongside diet and exercise. The key differences between the two medications are their dosage strengths — Ozempic is available in lower doses — and their indications.
While it can be prescribed off-label for weight loss, Ozempic is primarily FDA-approved to:
Control blood sugar levels in adults with type 2 diabetes mellitus
Lower the risk of major cardiovascular problems (e.g. heart attack, stroke) in adults with type 2 diabetes and heart disease
Reduce the risk of kidney decline in adults with type 2 diabetes and chronic kidney disease
And Wegovy is FDA-approved to:
Reduce excess body weight and manage weight long term in adults and children ages 12+ with obesity as well as adults with obesity or overweight who have at least one weight-related health condition (e.g. high blood pressure, diabetes)
Lower the risk of major cardiovascular problems (e.g. heart attack, stroke) in adults with heart disease and obesity
Treat a type of fatty liver disease called noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in certain adults (injection only)
When comparing the costs of Wegovy vs. Ozempic, it’s fair to say that both come with rather hefty price tags. However, Ozempic can sometimes be considered a cheaper alternative to Wegovy. That’s because its list price is $1,027.51 for a 28-day supply, and its out-of-pocket price on Ro is $900–$1,100 per month.
Novo Nordisk also offers an Ozempic Savings Card, which can reduce the price to $25 for those with private or commercial insurance coverage for Ozempic. And Ozempic also has cash-pay options that bring its monthly cost down to $199–$499, depending on the dosage.
People in low-income households with diabetes may qualify for free Ozempic through the manufacturer’s Patient Assistance Program.
Mounjaro and Zepbound (tirzepatide)
Mounjaro and Zepbound are injectable medications that also have the same active ingredient (tirzepatide) but different indications. Like semaglutide drugs, tirzepatide drugs are meant to be used along with lifestyle changes, including diet and exercise.
Mounjaro is FDA-approved to:
Control blood sugar levels in adults and children ages 10+ with type 2 diabetes mellitus
Zepbound is FDA-approved to:
Reduce excess body weight and manage weight long term in adults with obesity or overweight who have at least one weight-related health condition (e.g. high blood pressure, diabetes)
Treat moderate to severe obstructive sleep apnea in adults with obesity
Both drugs contain the same dosage strengths of tirzepatide, but one may be more likely to be covered by your insurance depending on the reason it’s prescribed.
When it comes to list prices, Mounjaro and Zepbound can be considered cheaper alternatives to Wegovy. Key words being “list prices.”
Mounjaro has a list price of $1,112.16 for a 28-day supply without insurance.
Zepbound has a list price of $1,086.37 for a 28-day supply without insurance.
In addition to single-dose pens, you can also get the Zepbound multi-dose KwikPen and single-dose vials. These are available for the following cash prices on Ro:
$299 per month: 2.5 mg dose
$399 per month: 5 mg dose
$449 per month: 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses (with manufacturer offer)
Eli Lilly, the maker of both drugs, offers Savings Cards for both medications.
For those with commercial insurance coverage, the card lowers the price of the drug to as little as $25 for a one- or three-month prescription.
For those with commercial insurance without coverage for Mounjaro, the card offers a maximum savings of up to $647 for a one-month prescription, or you can pay $499 for a one-month supply.
For those with commercial insurance coverage, the card lowers the price of the drug to as little as $25 for a one- or three-month prescription.
For those with commercial insurance without coverage for Zepbound, you can pay $499 for a one-month supply using the cash-pay options.
Saxenda (liraglutide)
Another injectable medication for weight loss, Saxenda (liraglutide), has a list price of $1,349.02. So, without insurance, it can cost just as much as Wegovy. With insurance, however, it’s possible that Saxenda can be a cheaper alternative to Wegovy — that is, of course, depending on factors such as whether your insurance covers the drug.
A key difference is that a generic version of Saxenda is now available as liraglutide. How much is it without insurance? According to SingleCare, you may pay as little as $157.40 for one 3-mL pen, which provides up to 30 days supply (depending on your dosage).
Qsymia (phentermine/topiramate)
Qsymia is an oral medication for weight loss. Without insurance, the average cost of Qsymia is $70–$98, which is less than the cost of Wegovy (though it’s not as effective at weight loss). The Qsymia Savings Card offers additional savings for people with commercial insurance (with or without coverage for Qsymia).
Contrave (naltrexone/bupropion)
Contrave is another oral medication for weight loss that can be cheaper than Wegovy. Without insurance, a month’s supply costs around $199–$210, according to GoodRx.
The Contrave Coupon Savings Card Program can bring the price down to $20 for those with insurance coverage for Contrave or $199 for those with insurance but without coverage for Contrave. Keep in mind, though, you must meet certain eligibility requirements to qualify for the discount.
Xenical and Alli (orlistat)
While both are oral weight loss medications, Xenical is a prescription drug, and Alli is available over-the-counter (OTC). According to GoodRx, the average price for Alli is $55–$90, while Xenical costs around $430–$460 without insurance. There is also a generic version of Xenical, orlistat, which can cost around $640–$725 without insurance.
Bottom line
Wegovy can be an expensive medication, but there are options that can help you bring the price of the medication down if you qualify.
Without insurance, Wegovy can cost $149–$399 per month if you pay cash on Ro.
With insurance, the cost of Wegovy may be lower, depending on your coverage. You may also qualify for the Wegovy Savings Card, which can help reduce out-of-pocket expenses.
If you don't have insurance or just prefer to pay in cash, Wegovy pens and pills are both available on Ro (if prescribed). The injection starts at $199 per month for the first two months (for a limited time), while the tablet starts at $149 per month.
If you don’t have insurance, there may be other ways to save, such as checking for pharmacy discounts and using coupon sites.
If the cost of Wegovy is too high, there may be more affordable alternatives that could work for you. Talk to your healthcare provider if you’re struggling to afford Wegovy.
Frequently asked questions (FAQs)
What is the cheapest way to get Wegovy?
If your insurance doesn’t cover Wegovy, the cheapest way to get Wegovy is by paying cash on Ro. With this cash-pay option, the Wegovy pill costs $149–$299 per month (with manufacturer offer), and the Wegovy injection costs $199–$399 per month.
What are the criteria for Wegovy to be covered by insurance?
For Wegovy to be covered by insurance, you’ll likely need a few things:
A valid prescription from a licensed healthcare provider
A medical condition that Wegovy is FDA-approved to treat (e.g. obesity, fatty liver disease)
Prior authorization from your provider attesting that Wegovy is a medically necessary medication for you
Step therapy (additional paperwork demonstrating that you’ve tried other weight loss options already without success; not all insurance plans require this)
Can you really get Wegovy for $25?
Yes, if you’re eligible for the official Wegovy savings offer from Novo Nordisk. To qualify, you need to have a commercial health insurance plan that covers Wegovy and meet other criteria (available on Novo’s website). Government-funded plans aren’t eligible for this $25 Wegovy savings offer.
Which is cheaper, Ozempic or Wegovy?
When paying with cash, the Wegovy pill is usually the cheapest option (starting at $149 per month), followed by the Wegovy injection (starting at $199 per month)— both of which are available (if prescribed) on Ro. When it comes to list prices, however, Ozempic ($1,027.51) is typically cheaper than Wegovy ($1,349.02).
How to afford Wegovy if your insurance doesn't cover it?
If your insurance doesn’t cover Wegovy, the most affordable option is to take advantage of the cash-pay prices on Ro. With these prices, you can get the Wegovy pill for $149–$299 (with manufacturer offer) and the Wegovy injection for $199–$399, depending on the dosage strength.
What's a cheaper alternative to Wegovy?
With the cash price of $149–$399 on Ro, Wegovy stands out as one of the cheapest GLP-1s on the market (as of publication). However, cheaper alternatives to Wegovy can include the Foundayo pill, Zepbound, or Saxenda, if your insurance plan covers those weight loss drugs.
If you don’t have insurance coverage, prescription weight loss pill Qsymia and over-the-counter Alli can be less expensive out of pocket as well.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Foundayo Important Safety Information: Read more about serious warnings and safety info.
References
Blundell, J., Finlayson, G., Axelsen, M., et al. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity & Metabolism, 19(9), 1242–1251. doi: 10.1111/dom.12932. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28266779/
Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet (London, England), 397(10278), 971–984. doi: 10.1016/S0140-6736(21)00213-0. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33667417/
Eli Lilly-a. (2026). How much should I expect to pay for Mounjaro (tirzepatide)?. Retrieved from https://pricinginfo.lilly.com/mounjaro
Eli Lilly-b. (2026). How much should I expect to pay for Zepbound (tirzepatide)?. Retrieved from https://pricinginfo.lilly.com/zepbound
GoodRx-a. (2024). Compare Alli Prices. Retrieved from https://www.goodrx.com/alli
GoodRx-b. (2024). Contrave (Naltrexone & Bupropion) Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/contrave?form=tablet&dosage=8mg-90mg&quantity=120&label_override=contrave
GoodRx-c. (2024). Generic Xenical Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/xenical
GoodRx-d. (2024). Xenical Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/xenical?label_override=xenical&form=capsule&dosage=120mg&quantity=90&slug=xenical
Institute for Clinical and Economic Review. (2025). Affordable Access to GLP-1 Obesity Medications: Strategies to Guide Market Action and Policy Solutions. Retrieved from https://icer.org/wp-content/uploads/2025/04/Affordable-Access-to-GLP-1-Obesity-Medications-_-ICER-White-Paper-_-04.09.2025.pdf
Mehta, A., Marso, S. P., & Neeland, I. J. (2017). Liraglutide for weight management: a critical review of the evidence. Obesity Science & Practice, 3(1), 3–14. doi: 10.1002/osp4.84. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28392927
Novo Nordisk-a. (2026). Find out the list price for Ozempic. Retrieved from https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
Novo Nordisk-b. (2026). Get savings and support for Ozempic. Retrieved from https://www.novocare.com/diabetes/products/ozempic/savings-offer.html
Novo Nordisk-c. (2026). Patient Assistance Program. Retrieved from https://www.novocare.com/diabetes/help-with-costs/pap.html
Novo Nordisk-d. (2026). Price guide. Retrieved from https://www.novocare.com/content/dam/novonordisk/novocare/redesign/pdf/Wegovy_Price_Guide.pdf
Novo Nordisk-e. (2026). Start saving on Wegovy. Retrieved from https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
Novo Nordisk-f. (2026). What is the list price for Saxenda and will it impact me? Retrieved from https://www.novocare.com/obesity/products/saxenda/explaining-list-price.html
Phillips, A. & Clements, J. N. (2022). Clinical review of subcutaneous semaglutide for obesity. Journal of Clinical Pharmacy and Therapeutics, 47(2), 184–193. doi: 10.1111/jcpt.13574. Retrieved from https://pubmed.ncbi.nlm.nih.gov/34964141/
Pratt, E., Ma, X., Liu, R., et al. (2023). Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants. Diabetes, Obesity & Metabolism, 25(9), 2634–2641. doi: 10.1111/dom.15184. Retrieved from https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15184
Qsymia. (2024). Prescription Weight Loss with Qsymia. Retrieved from https://qsymia.com/
Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2022). Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine, 70(1), 5–13. doi: 10.1136/jim-2021-001952. Retrieved from https://pubmed.ncbi.nlm.nih.gov/34706925/
Teva. (2025). Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss. Retrieved from https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-Announces-FDA-Approval-and-Launch-of-Generic-Saxenda-liraglutide-injection--First-Generic-GLP-1-Indicated-for-Weight-Loss/default.aspx
U.S. Food and Drug Administration (FDA). (2017). Alli (orlistat) capsules, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021887Orig1s009lbl.pdf
U.S. Food and Drug Administration (FDA-a). (2025). Highlights of Prescribing Information: Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200063s024s026lbl.pdf
U.S. Food and Drug Administration (FDA-a). (2026). Highlights of Prescribing Information: Foundayo (orforglipron) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2026). Highlights of Prescribing Information: Liraglutide injection, for subcutaneous use. Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/625ac780-70a9-41e4-a892-bcba0f803f1c/spl-doc
U.S. Food and Drug Administration (FDA-c). (2026). Highlights of Prescribing Information: Mounjaro (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s009lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
U.S. Food and Drug Administration (FDA). (2024). Highlights of Prescribing Information: Qsymia (phentermine and topiramate extended-release capsules), for oral use, CIV. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022580s029lbl.pdf
U.S. Food and Drug Administration (FDA-d). (2026). Highlights of Prescribing Information: Rybelsus (semaglutide) tablets for oral use / Ozempic (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213051s030lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2025). Highlights of Prescribing Information: Saxenda (liraglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206321s022lbl.pdf
U.S. Food and Drug Administration (FDA-e). (2026). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use / Wegovy (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf
U.S. Food and Drug Administration (FDA). (2022). Highlights of Prescribing Information: Xenical (orlistat) capsules, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020766s038lbl.pdf
U.S. Food and Drug Administration (FDA-f). (2026). Highlights of Prescribing Information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf
Wilding, J., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. doi: 10.1056/NEJMoa2032183. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33567185/















